Interestingly, CD44 and ALDH1 were also highly expressed in CTCs from the liver patient (Supplementary Figure S6), suggesting that these two markers may be also conserved in CTCs in liver cancer. This evidence concerns the gene ALDH1A1 and liver cancer.